Rigel makes Veppanu available across US

Study begins testing KJ‑103 in TROP2‑positive cancers

New alliance aims to accelerate development of future medicines

KUP101 enters clinic for advanced solid tumours

SMC acceptance offers new option for patients

Delayed‑release mercaptamine approved for routine use

Stablepharma’s thermostable td shot delivers strong phase 1 data

Regulator backs gene therapy for PKP2-ACM

Programme celebrates partnership excellence

Acalabrutinib combinations approved for CLL and MCL